Luce Emerson is a former sell-side banker with a broad range of capital markets experience. She continues to follow markets closely, with a particular focus on retail, financials and entertainment.
With WeWork stock, there are obstacles to its ability to grow and generate profits. People like to claim that “this time is different.” In this particular case, it just is not.
Of course, the medical opportunity is massive, but Tilray competitor, Canopy Growth (NYSE:CGC), has been aggressively pursuing a multi-pronged approach that inherently diversifies the future revenue streams. CGC’s vision for THC as an ingredient in an array of consumer products separates them from an increasingly crowded industry.